REQUEST A DEMO
Total
USD $0.00
Search more companies

CXI Healthcare Technology Group Limited (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: CXI Healthcare Technology Group Limited Profile Updated: August 27, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

CXI Healthcare Technology Group Limited engages in health food and supplements manufacturing and distribution. The company's product line up includes blood sugar supplements, growth promoters, diabetic prevention pills, immune boosters, and menopause supplements in the form of capsules, liquid, and tea bags. The company's business location is in Fuzhou City China. CXI Healthcare Technology Group Limited was incorporated in 2009 and is based in Grand Cayman, Cayman Islands.

Headquarters
3F, Century Yard, Cricket Square, PO Box 902, Grand Cayman, KY1-1103, Cayman Islands
Cayman Islands;

Contact Details: Purchase the CXI Healthcare Technology Group Limited report to view the information.

Website: http://www.ckhfnh.co.kr/

Basic Information
Total Employees:
Purchase the CXI Healthcare Technology Group Limited report to view the information.
Financial Auditors:
Purchase the CXI Healthcare Technology Group Limited report to view the information.
Incorporation Date:
February 24, 2009
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
56.13%
Subsidiaries
복건영생활력생물공정유한공사 (China)
Company Performance
Financial values in the chart are available after CXI Healthcare Technology Group Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-1.93%
Total operating revenue
-1.88%
Operating profit (EBIT)
164.84%
EBITDA
33.59%
Net Profit (Loss) for the Period
294.34%
Total assets
17.38%
Total equity
17.72%
Operating Profit Margin (ROS)
17.18%
Net Profit Margin
31.76%
Return on Equity (ROE)
4.57%
Debt to Equity Ratio
-0.19%
Quick Ratio
29.66%
Cash Ratio
28.57%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?